Journal article
Alloimmune neonatal neutropenia: can we afford the consequences of a missed diagnosis?
Journal of Paediatrics and Child Health, Vol.42(1-2), pp.59-61
2006
Abstract
The incidence of alloimmune neonatal neutropenia (ANN) is poorly defined. The reported incidence is less than or equal to 0.1%. This prospective study of unselected pregnancies found an incidence of 0.81% based on results of screening 247 'full term' cord blood samples. Alloimmune neonatal neutropenia occurred more frequently in this population than expected from published historical data. Advances in techniques for antineutrophil antibody screening may have contributed to the higher incidence found in this study. The frequency of ANN supports increased surveillance and confirmatory serological testing in infants with unexplained neutropenia.
Details
- Title
- Alloimmune neonatal neutropenia: can we afford the consequences of a missed diagnosis?
- Authors
- Bronwyn A Williams (Author) - Queensland Pathology Health ServiceYoke Lin Fung (Author) - Queensland Pathology Health Service
- Publication details
- Journal of Paediatrics and Child Health, Vol.42(1-2), pp.59-61
- Publisher
- Wiley-Blackwell Publishing Ltd.
- Date published
- 2006
- DOI
- 10.1111/j.1440-1754.2006.00774.x
- ISSN
- 1034-4810
- Organisation Unit
- School of Health - Biomedicine; University of the Sunshine Coast, Queensland; School of Health and Sport Sciences - Legacy; School of Health and Behavioural Sciences - Legacy
- Language
- English
- Record Identifier
- 99450055602621
- Output Type
- Journal article
Metrics
4 File views/ downloads
511 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Web Of Science research areas
- Pediatrics
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites